ClinicalTrials.Veeva

Menu

Safety of Different Forms of Creatine (NB9)

Texas A&M University logo

Texas A&M University

Status

Completed

Conditions

Nutritional Supplements

Treatments

Dietary Supplement: Creatine nitrate, high dose
Dietary Supplement: Placebo
Dietary Supplement: Creatine nitrate, low dose

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03039829
IRB2015-0684

Details and patient eligibility

About

This study will aim to determine whether ingesting creatine nitrate (CrN) at higher doses will differentially affect hemodynamic variables compared to a placebo.

Full description

This study will examine the short-term (7 day) characteristics of ingesting creatine nitrate (CrN) compared to placebo on Chem-15 blood safety, heart rate, blood pressure, heart rate and blood pressure reactivity and self-reported side effects.

Enrollment

38 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Apparently healthy
  • At least 6 months immediate prior history of resistance training including bench press and leg press or squat

Exclusion criteria

  • A history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease
  • Use of prescription medication (birth control is allowed)
  • Pregnant or nursing or plan to become pregnant during the next month
  • Creatine or nitrate use in the last eight weeks
  • History of smoking
  • History of drinking (i.e., 12 drinks per week or more)
  • Use of nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen (Advil, Motrin, Nuprin, etc.), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene)

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

38 participants in 3 patient groups, including a placebo group

Creatine nitrate, low dose
Experimental group
Description:
Creatine nitrate at 3.0 grams (2.0 grams creatine; 1.0 gram nitrate, 3.0 grams dextrose)
Treatment:
Dietary Supplement: Creatine nitrate, low dose
Creatine nitrate, high dose
Active Comparator group
Description:
Creatine nitrate at 6.0 grams (4.0 grams creatine; 2.0 grams nitrate)
Treatment:
Dietary Supplement: Creatine nitrate, high dose
Placebo
Placebo Comparator group
Description:
Placebo at 6.0 grams dextrose
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems